Israel Englander’s Concord Acquisition Corp III Units, each consisting of one share of Class A Common Stock and one-half of one Warrant CNDB.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-25,000
Closed -$252K 7237
2022
Q3
$252K Hold
25,000
﹤0.01% 5496
2022
Q2
$251K Sell
25,000
-200,000
-89% -$2.01M ﹤0.01% 5506
2022
Q1
$2.27M Sell
225,000
-685,000
-75% -$6.93M ﹤0.01% 3761
2021
Q4
$9.27M Buy
+910,000
New +$9.25M ﹤0.01% 2221

Other funds holding CNDB.U

Israel Englander's CNDB.U Position: Q4 2022 in Review

Israel Englander sold out of Concord Acquisition Corp III Units, each consisting of one share of Class A Common Stock and one-half of one Warrant (CNDB.U) in Q4 2022, closing a stake of 25,000 shares — an estimated $252K sold.

Israel Englander first reported a position in CNDB.U in Q4 2021 and held it in 4 quarters. The position peaked at $9.27M in Q4 2021. 13 funds tracked by Wall St. Rank hold CNDB.U as of Q4 2022.

  • Israel Englander reported no remaining Concord Acquisition Corp III Units, each consisting of one share of Class A Common Stock and one-half of one Warrant position as of Q4 2022 after selling out during the quarter.
  • Israel Englander sold 25,000 Concord Acquisition Corp III Units, each consisting of one share of Class A Common Stock and one-half of one Warrant shares in Q4 2022, an estimated $252K.
  • Israel Englander first reported a position in Concord Acquisition Corp III Units, each consisting of one share of Class A Common Stock and one-half of one Warrant in Q4 2021 and held it in 4 quarters.
  • Israel Englander's Concord Acquisition Corp III Units, each consisting of one share of Class A Common Stock and one-half of one Warrant position peaked at $9.27M in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Concord Acquisition Corp III Units, each consisting of one share of Class A Common Stock and one-half of one Warrant as of Q4 2022.

Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.